Ubs Group Ag Eli Lilly & CO Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $33.7 Million - $41.9 Million	43,640 Added 30.61%	186,194 $165 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $17.6 Million - $22.1 Million	-24,346 Reduced 14.59%	142,554 $129 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $29.7 Million - $39.7 Million	-50,092 Reduced 23.08%	166,900 $130 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $72.8 Million - $85.9 Million	138,692 Added 177.13%	216,992 $126 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $16 Million - $22.1 Million	36,800 Added 88.67%	78,300 $42.1 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.54 Million - $2.06 Million	4,400 Added 11.86%	41,500 $19.5 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $2.36 Million - $2.77 Million	-7,600 Reduced 17.0%	37,100 $12.7 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $12.8 Million - $14.9 Million	39,700 Added 794.0%	44,700 $16.4 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $1.48 Million - $1.69 Million	5,000 New	5,000 $1.62 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $4.2 Million - $5.22 Million	-17,896 Reduced 38.99%	28,000 $8.02 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5.84 Million - $7.25 Million	-25,990 Reduced 36.15%	45,896 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.48 Million - $3.05 Million	11,200 Added 18.46%	71,886 $16.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $48.9 Million - $63.2 Million	-270,700 Reduced 81.69%	60,686 $13.9 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $38.3 Million - $49.6 Million	233,086 Added 237.12%	331,386 $61.9 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $4.83 Million - $6.39 Million	37,000 Added 60.36%	98,300 $16.6 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $32.7 Million - $38.1 Million	-295,000 Reduced 82.8%	61,300 $6.79 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $34.7 Million - $40.8 Million	311,300 Added 691.78%	356,300 $46.2 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $4.71 Million - $5.28 Million	44,500 Added 8900.0%	45,000 $5.21 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $136,260 - $156,384	-1,800 Reduced 78.26%	500 $43,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,000 Added 666.67%	2,300 $189,000
Q1 2017 Nov 14, 2017	BUY	N/A	300	300 $25,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.2 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account